Skip to main content

Table 1 Characteristics of the participants enrolled in the study

From: Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings

Groups median (range) Immunologic non responders (n = 23) Matched responders (n = 40) Treatment failure (n = 18) Virologic non responders (n = 25) P value viremic vs aviremic
Age: years 42 (23–60) 39.5 (25–62) 37.5 (24–52) 35 (18–55) 0.016
Baseline CD4: cells/cmm 270 (14–380) 283.5 (25–352) 142.5 (8–358) 159 (22–350) < 0.0001
Enrolment CD4: cells/cmm 227 (13–360) 479 (246–1387) 89 (19–331) 317 (99–809) < 0.0001
Viral load (copies/ml) < 40 < 40 63,165 (1891–526,175) 12,366 (1056–889,079) < 0.0001